Correction: Pharmacokinetics and Safety of Erenumab after a Single Subcutaneous Injection Dose in Healthy Chinese Subjects

Clin Drug Investig. 2023 Dec;43(12):973-974. doi: 10.1007/s40261-023-01321-3.

Authors

Qi Shen¹, Ying Jin¹, Xiangjie Di¹, Chao Hu¹, Runhan Liu¹, Ying Wang¹, Xiaohui Qi¹, Yongsheng Wang¹, Zhenlei Wang²

Affiliations

¹ Clinical Trial Center/NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drug, West China Hospital of Sichuan University, No.5 Telecom Road, Wuhou District, Chengdu, 610041, China.
² Clinical Trial Center/NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drug, West China Hospital of Sichuan University, No.5 Telecom Road, Wuhou District, Chengdu, 610041, China. wangzhenlei@wchscu.cn.

PMID: 37991687
DOI: 10.1007/s40261-023-01321-3

No abstract available

Publication types

Published Erratum